Media Coverage · October 22, 2018
Acticor Biotech internationalise son tour de table – Les Echos [FR]
October 2018. Spin-off de l’INSERM, Acticor Biotech avance à grand pas dans son programme phare, l’ACT017, un traitement d’urgence …
Download full text article (PDF, French)
Read next in 'Media Coverage'
- ACT017 : un fragment d’anticorps dont l’ACTion antithrombotique est prometteuse !
- Novel antiplatelet could circumvent bleeding risk for stroke patients
- Experimental antiplatelet compound for acute stroke shows promise
- New drug to prevent clots clears safety hurdle
- New blood thinner may prevent stroke, without risk for bleeding